Keywords: bristol-myers, squibb, 3rd-qtr, income, down, 388m, sales
Bristol-Myers Squibb's 3rd-qtr income down 65% to $388M, as sales fall 12.5%
Article | 06 November 2006
USA-based drug major Bristol-Myers Squibb reported income for the third quarter of 2006 of $388.0 million, or $0.17 per share, down 65% on the ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
